Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 16,475 | 13,846 | 12,781 | 11,841 | 11,041 |
| Cost of Goods | 3,353 | 3,026 | 2,598 | 2,028 | 1,376 |
| Gross Profit | 13,122 | 10,820 | 10,183 | 9,813 | 9,666 |
| Operating Expenses | 11,925 | 10,964 | 9,895 | 7,614 | 7,508 |
| Operating Income | 1,197 | -144 | 288 | 2,199 | 2,158 |
| Interest Expense | 31 | 29 | 22 | 56 | 209 |
| Other Income | -140 | -132 | -131 | -134 | -140 |
| Pre-tax Income | 1,027 | -305 | 134 | 2,010 | 1,810 |
| Income Tax | 412 | 27 | 157 | -2,008 | -306 |
| Net Income Continuous | 615 | -332 | -22 | 4,018 | 2,116 |
| Net Income | $615 | $-332 | $-22 | $4,018 | $2,116 |
| EPS Basic Total Ops | 0.01 | -0.01 | 0.00 | 0.06 | 0.03 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | 0.00 | 0.06 | 0.03 |
| EPS Diluted Total Ops | 0.01 | -0.01 | 0.00 | 0.05 | 0.03 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | 0.00 | 0.05 | 0.03 |
| EBITDA(a) | $2,324 | $1,031 | $1,562 | $3,400 | $2,956 |